GAVI raises $567 million of $2 billion goal to buy COVID-19 vaccines for poor

LONDON (Reuters) – The GAVI vaccines alliance said on Thursday it had raised $567 million towards an initial goal of $2 billion from international donors for an Advanced Market Commitment to buy future COVID-19 vaccines for poor countries.

The deal would help secure enough COVID-19 vaccine doses – when the shots have been developed – for poor countries to immunise healthcare workers and those at high risk, it said, as well as creating a “buffer of doses” for use when needed.

(This story corrects to make clear a portion of the target has been raised, not full amount)

Reporting by Kate Kelland; Editing by Alex Richardson

View original article here Source

Related Posts